A carregar...
Immunotherapy of Head and Neck Cancer: Current and Future Considerations
Patients with head and neck squamous cell carcinoma (HNSCC) are at considerable risk for death, with 5-year relative survival rates of approximately 60%. The profound multifaceted deficiencies in cell-mediated immunity that persist in most patients after treatment may be related to the high rates of...
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Hindawi Publishing Corporation
2009
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2723756/ https://ncbi.nlm.nih.gov/pubmed/19680453 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2009/346345 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|